NantKwest
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch NantKwest and buy or sell other stocks, ETFs, and their options commission-free!About NK
ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases.
CEORichard Adcock, MBA
CEORichard Adcock, MBA
Employees680
Employees680
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded2014
Founded2014
Employees680
Employees680
NK Key Statistics
Market cap4.16B
Market cap4.16B
Price-Earnings ratio-4.95
Price-Earnings ratio-4.95
Dividend yield—
Dividend yield—
Average volume16.62M
Average volume16.62M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$4.27
52 Week high$4.27
52 Week low$1.83
52 Week low$1.83
Stock Snapshot
As of today, NantKwest(NK) shares are valued at $4.22. The company's market cap stands at 4.16B, with a P/E ratio of -4.95.
On 2025-12-19, NantKwest(NK) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for NantKwest(NK) stock has reached 0, versus its average volume of 16.62M.
Over the past 52 weeks, NantKwest(NK) stock has traded between a high of $4.27 and a low of $1.83.
Over the past 52 weeks, NantKwest(NK) stock has traded between a high of $4.27 and a low of $1.83.
People also own
Based on the portfolios of people who own NK. This list is generated using Robinhood data, and it’s not a recommendation.